Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giulia Grisendi

Showing results (71-80 of 82) with videos related to

Pageof 9
Sort By:
Cancers|November 27, 2021
The Release of Inflammatory Mediators from Acid-Stimulated Mesenchymal Stromal Cells Favours Tumour Invasiveness and Metastasis in OsteosarcomaSofia Avnet, Silvia Lemma, Margherita Cortini, et al.
Cancer Research|April 15, 2010
Adipose-derived mesenchymal stem cells as stable source of tumor necrosis factor-related apoptosis-inducing ligand delivery for cancer therapyGiulia Grisendi, Rita Bussolari, Luigi Cafarelli, et al.
Cells|September 23, 2022
Human Adipose Mesenchymal Stromal/Stem Cells Improve Fat Transplantation PerformanceMaria Serena Piccinno, Tiziana Petrachi, Marco Pignatti, et al.
Theranostics|February 28, 2019
MSC-Delivered Soluble TRAIL and Paclitaxel as Novel Combinatory Treatment for Pancreatic AdenocarcinomaFilippo Rossignoli, Carlotta Spano, Giulia Grisendi, et al.
Tissue Engineering. Part C, Methods|July 13, 2013
Transportation conditions for prompt use of ex vivo expanded and freshly harvested clinical-grade bone marrow mesenchymal stromal/stem cells for bone regenerationElena Veronesi, Alba Murgia, Anna Caselli, et al.
Scientific Reports|February 12, 2019
Soluble TRAIL Armed Human MSC As Gene Therapy For Pancreatic CancerCarlotta Spano, Giulia Grisendi, Giulia Golinelli, et al.
NPJ Precision Oncology|February 1, 2024
Autologous anti-GD2 CAR T cells efficiently target primary human glioblastomaChiara Chiavelli, Malvina Prapa, Giulia Rovesti, et al.
Leukemia|March 17, 2023
Inhibition of ERK1/2 signaling prevents bone marrow fibrosis by reducing osteopontin plasma levels in a myelofibrosis mouse modelElisa Bianchi, Sebastiano Rontauroli, Lara Tavernari, et al.
Cell Reports. Medicine|August 21, 2024
Combining gemcitabine and MSC delivering soluble TRAIL to target pancreatic adenocarcinoma and its stromaGiulia Grisendi, Massimiliano Dall'Ora, Giulia Casari, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 6, 2017
Blocking Tumor-Educated MSC Paracrine Activity Halts Osteosarcoma ProgressionS Rubina Baglio, Tonny Lagerweij, Maria Pérez-Lanzón, et al.
Pageof 9

Showing results (71-80 of 82) with videos related to

Sort By:
Pageof 9
Cancers|November 27, 2021
The Release of Inflammatory Mediators from Acid-Stimulated Mesenchymal Stromal Cells Favours Tumour Invasiveness and Metastasis in OsteosarcomaSofia Avnet, Silvia Lemma, Margherita Cortini, et al.
Cancer Research|April 15, 2010
Adipose-derived mesenchymal stem cells as stable source of tumor necrosis factor-related apoptosis-inducing ligand delivery for cancer therapyGiulia Grisendi, Rita Bussolari, Luigi Cafarelli, et al.
Cells|September 23, 2022
Human Adipose Mesenchymal Stromal/Stem Cells Improve Fat Transplantation PerformanceMaria Serena Piccinno, Tiziana Petrachi, Marco Pignatti, et al.
Theranostics|February 28, 2019
MSC-Delivered Soluble TRAIL and Paclitaxel as Novel Combinatory Treatment for Pancreatic AdenocarcinomaFilippo Rossignoli, Carlotta Spano, Giulia Grisendi, et al.
Tissue Engineering. Part C, Methods|July 13, 2013
Transportation conditions for prompt use of ex vivo expanded and freshly harvested clinical-grade bone marrow mesenchymal stromal/stem cells for bone regenerationElena Veronesi, Alba Murgia, Anna Caselli, et al.
Scientific Reports|February 12, 2019
Soluble TRAIL Armed Human MSC As Gene Therapy For Pancreatic CancerCarlotta Spano, Giulia Grisendi, Giulia Golinelli, et al.
NPJ Precision Oncology|February 1, 2024
Autologous anti-GD2 CAR T cells efficiently target primary human glioblastomaChiara Chiavelli, Malvina Prapa, Giulia Rovesti, et al.
Leukemia|March 17, 2023
Inhibition of ERK1/2 signaling prevents bone marrow fibrosis by reducing osteopontin plasma levels in a myelofibrosis mouse modelElisa Bianchi, Sebastiano Rontauroli, Lara Tavernari, et al.
Cell Reports. Medicine|August 21, 2024
Combining gemcitabine and MSC delivering soluble TRAIL to target pancreatic adenocarcinoma and its stromaGiulia Grisendi, Massimiliano Dall'Ora, Giulia Casari, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 6, 2017
Blocking Tumor-Educated MSC Paracrine Activity Halts Osteosarcoma ProgressionS Rubina Baglio, Tonny Lagerweij, Maria Pérez-Lanzón, et al.
Pageof 9